LG CNS Launches Innovative Pharma-Specific Manufacturing Solutions at CPHI Milan 2026

Introduction

In a significant move to bolster its manufacturing AX (AI Transformation) business, LG CNS has taken center stage at the world’s largest pharmaceutical and biotech exhibition, CPHI Milan 2026. This premier event, which attracts thousands of industry professionals, serves as an ideal platform for LG CNS to showcase its cutting-edge smart factory technologies specifically designed for the pharmaceutical sector.

The CPHI Milan Experience

Taking place in Milan, this flagship event of the CPHI series draws approximately 60,000 visitors and 3,000 companies from over 160 countries. For LG CNS, it represents a unique opportunity, especially as the sole Korean company selected to participate in the newly created "AI Tech" zone at this year’s exhibition.

The theme of LG CNS's booth, "Autonomous Factory in Pharma," emphasizes its commitment to revolutionizing the way pharmaceutical companies approach manufacturing. The focus lies on introducing three pivotal smart factory solutions that seamlessly connect factory design, production operations, and quality management, effectively enhancing the overall manufacturing process.

Innovative Smart Factory Solutions

The showcased solutions are broken down into three core areas:

1. Factory Design:
LG CNS introduces Factova Worldworks, a digital twin-based virtual validation simulator. This innovative tool allows pharmaceutical companies to visualize their factory layouts in 3D. By simulating various configurations, stakeholders can optimize the placement of crucial manufacturing equipment, plan worker movement, and manage the flow of raw materials effectively.

This technology is especially important in pharmaceutical contexts where different areas of the factory serve distinct purposes. Cleanrooms and production zones must be meticulously designed to prevent contamination, requiring careful planning of worker access routes.

2. Production Operations:
For the production stage, LG CNS unveils Factova Control, a data standardization and equipment control solution. This tool automatically translates complex process data into a uniform format, facilitating immediate responses when adjustments are needed.

Utilizing AI technology, Factova Control monitors critical parameters—including electrical current and temperature—to predict potential equipment failures, identifying the necessity for maintenance before a breakdown occurs. This proactive approach to equipment management aims to minimize downtime and ensure continuity in pharmaceutical production.

3. Quality Management:
The third component addresses quality control concerns through a comprehensive solution that evaluates key data points such as production volume and temperature fluctuations. By systematically analyzing this information, the solution detects quality issues and facilitates root-cause analyses.

Notably, an AI agent automates the drafting of the Annual Product Quality Review (APQR), a critical compliance tool for pharmaceutical firms. This automation dramatically reduces the time required for this traditionally labor-intensive task by over 90%, ensuring faster and more accurate regulatory reporting.

Conclusion

Eddie Jang, Head of the Chemical/Battery Division at LG CNS, remarked, "The manufacturing AX solutions we are showcasing at this exhibition are tailored to pharma, allowing us to support our customers with intelligent automation across the entire manufacturing process, from factory design to quality management."

As LG CNS illustrates its innovative approach at CPHI Milan 2026, it positions itself as a technology leader, ready to tackle the challenges of pharmaceutical production with precision and efficiency. This initiative not only represents a leap forward for LG CNS but also sets a new standard for the pharmaceutical industry, as it transitions into a more automated future.

About LG CNS

LG CNS is a leading Korean company specializing in AI transformation and remains at the forefront of integrating advanced technologies such as robotics, cloud computing, and smart engineering into various sectors, including finance and public services. As the industry evolves, LG CNS continues to pioneer smart factory solutions that anticipate and meet the rigorous demands of the pharmaceutical industry and beyond.